Search for: "Pharmaceutical Research and Manufacturers of America"
Results 381 - 400
of 410
Sorted by Relevance
|
Sort by Date
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
15 Mar 2007, 2:12 am
Hoffmann-La Roche AG and its American subsidiary, the manufacturers of Tamiflu, an antiviral pharmaceutical preparation for the treatment and prevention of influenza. [read post]
6 Jan 2021, 5:01 am
The deal allows Chinese companies to participate in the growing market of European renewable energy and affords them more freedom in manufacturing. [read post]
11 Feb 2012, 9:51 am
Not arguing that development should move in-house, but focusing on dual-use (commercial/research) discoveries. [read post]
3 Mar 2023, 5:16 am
The cyber strategy recognizes that new authorities will be required to set minimum cybersecurity requirements for certain sectors—such as “food and agriculture, government facilities, and ‘critical manufacturing’—including vaccine-makers, pharmaceuticals, and mask manufacturers”—therefore delaying regulation by federal agencies until Congress passes the appropriate legislation. [read post]
4 Jun 2012, 7:53 pm
Connecticut Retirement Plans and Trust FundsDocket: 11-1085Issue(s): (1) Whether, in a misrepresentation case under Securities and Exchange Commission Rule 10b-5, the district court must require proof of materiality before certifying a plaintiff class based on the fraud-on-the-market theory; and (2) whether, in such a case, the district court must allow the defendant to present evidence rebutting the applicability of the fraud-on-the-market theory before certifying a plaintiff class based on that… [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
10 Apr 2023, 9:01 pm
At the close of business on Good Friday, federal judge Matthew Kacsmaryk released a ruling in Alliance for Hippocratic Medicine vs. [read post]
19 Feb 2016, 11:57 am
No bad cases, because we don’t do the other side’s research for them.Bauman, of course, held that unless a corporation is incorporated or has its principal place of business in a particular jurisdiction, it’s hard as heck for a non-resident plaintiff (one not injured in that jurisdiction) to sue such a corporation there. [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
31 Jul 2018, 10:40 am
The state benefits from a strong manufacturing base and an educated workforce. [read post]
31 Oct 2009, 4:06 pm
The company’s Wallingford plant contained a production line that used to manufacture resins. [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
22 Aug 2023, 7:34 pm
Some of them reflect now aging views of a post colonial era that is rapidly fading into (far more useful) myth (the South America and South African cases in particular is useful here), or as a platform for continuing to develop the idea of a replacement strategy for the current lineup of state based economics related leadership (the Chinese position). [read post]
3 Jul 2022, 7:15 am
The longest-standing democracy in the world looks and feels bitterly divided. [read post]
16 May 2011, 8:08 pm
"[The following article includes a table which lists out the statutorily permissible uses of polygraph examination in the different state jurisdictions of the United States of America: Henry T. [read post]
31 Jul 2017, 7:00 am
See generally Brief of Amici Curiae American Tort Reform Ass’n & Pharmaceutical Research and Manufacturers of America (Oct. 18, 2016); Brief of Washington Legal Fdtn. as Amicus Curiae (Oct. 18, 2016). [read post]
7 Jan 2011, 6:44 am
We are reposting this edition of “Petitions to watch,” which features cases up for consideration at the Justices’ January 7 conference. [read post]
6 Oct 2021, 2:01 pm
MNEs to invest in research and development (R&D) in the U.S. due to reduced after-tax income from intellectual property (IP) that has been located abroad. [read post]
